Clinical implications of autoantibody screening in patients with autoimmune myositis

References

• Dalakas MC. Muscle biopsy findings in inflammatory myopathies. Rheum Dis Clin North Am 2002; 28: 779–798
   PubMed Web of Science ®Google Scholar
• Dalakas MC, Hohlfeld R. Polymyositis and dermatomyositis. Lancet 2003; 362: 971–982
   PubMed Web of Science ®Google Scholar
• Nagaraju K, Casciola-Rosen L, Lundberg I, Rawat R, Cutting S, Thapliyal R, et al. Activation of the endoplasmic reticulum stress response in autoimmune myositis. Arthritis Rheum 2005; 52: 1824–1835
   PubMed Web of Science ®Google Scholar
• Dalakas MC. Polymyositis, dermatomyositis and inclusion-body myositis. N Engl J Med 1991; 325: 1487–1498
   PubMed Web of Science ®Google Scholar
• Civatte M, Schleinitz N, Krammer P, Fernandez C, Guis S, Veit V, et al. Class I MHC detection as a diagnostic tool in noninformative muscle biopsies of patients suffering from dermatomyositis (DM). Neuropathol Appl Neurobiol 2003; 29: 546–552
   PubMedGoogle Scholar
• Targoff IN. Update on myositis-specific and myositis-associated autoantibodies. Curr Opin Rheumatol 2000; 12: 475–481
   PubMed Web of Science ®Google Scholar
• Zampieri S, Ghirardello A, Iaccarino L, Tarricone E, Gambari PF, Doria A. Anti-Jo-1 antibodies. Autoimmunity 2005; 38: 73–78
   PubMed Web of Science ®Google Scholar
• Ghirardello A, Zampieri S, Iaccarino L, Tarricone E, Bendo R, Gambari PF, et al. Anti-Mi-2 antibodies. Autoimmunity 2005; 38: 79–83
   PubMed Web of Science ®Google Scholar
• Franceschini F, Cavazzana I. Anti-Ro/SSA and anti-La/SSB antibodies. Autoimmunity 2005; 38: 55–63
   PubMed Web of Science ®Google Scholar
• Migliorini P, Baldini C, Rocchi V, Bombardieri S. Anti-Sm and anti-RNP antibodies. Autoimmunity 2005; 38: 47–54
   PubMed Web of Science ®Google Scholar
• Franceschini F, Cavazzana I, Generali D, Quinzanini M, Viardi L, Ghirardello A, et al. Anti-Ku antibodies in connective tissue diseases: Clinical and serological evaluation of 14 patients. J Rheumatol 2002; 29: 1393–1397
   PubMed Web of Science ®Google Scholar
• Love LA, Leff RL, Fraser DD, Targoff IN, Dalakas M, Plotz PH, et al. A new approach to the classification of idiopathic inflammatory myopathy: Myositis-specific autoantibodies define useful homogeneous patient groups. Medicine 1991; 70: 360–374
   PubMed Web of Science ®Google Scholar
• Levine SM, Rosen A, Casciola-Rosen LA. Anti-aminoacyl tRNA synthetase immune responses: Insights into the pathogenesis of the idiopathic inflammatory myopathies. Curr Opin Rheumatol 2003; 15: 708–713
   PubMed Web of Science ®Google Scholar
• Ghirardello A, Zampieri S, Iaccarino L, Tarricone E, Tonello M, Bendo R, et al. Gli anticorpi miosite specifici e miosite associati nelle miopatie infiammatorie idiopatiche: Studio sierologico di 46 pazienti. Reumatismo 2005; 57: 22–28
   PubMedGoogle Scholar
• Bohan A, Peter JB. Polymyositis and dermatomyositis (first of two parts). N Engl J Med 1975; 292: 344–347
   PubMed Web of Science ®Google Scholar
• Marguerie C, Bunn CC, Beynon HL, Bernstein RM, Hughes JM, So AK, et al. Polymyositis, pulmonary fibrosis and autoantibodies to aminoacyl-tRNA synthetase enzymes. Q J Med 1990; 77: 1019–1038
   PubMedGoogle Scholar
• Imbert-Masseau A, Hamidou M, Agard C, Grolleau J-Y, Cherin P. Antisynthetase syndrome. Joint Bone Spine 2003; 70: 161–168
   PubMed Web of Science ®Google Scholar
• Euwer RL, Sontheimer RD. Dermatologic aspects of myositis. Curr Opin Rheumatol 1994; 6: 583–589
   PubMedGoogle Scholar
• Forman MS, Nakamura M, Mimori T, Gelpi C, Hardin J. Detection of antibodies to small nuclear ribonucleoproteins and small ribonucleoproteins using unlabeled extracts. Arthritis Rheum 1985; 28: 1356–1361
   PubMed Web of Science ®Google Scholar
• Merril C, Goldman D, Sedman S, Ebert M. Ultrasensitive stain for proteins in polyacrylamide gels shows regional variations in cerebrospinal fluid proteins. Science 1981; 211: 1437–1438
   PubMed Web of Science ®Google Scholar
• Salviati G, Betto R, Danieli Betto D. Polymorphism of myofibrillar proteins of rabbit skeletal-muscle fibers. An electrophoretic study of single fibers. Biochem J 1982; 207: 261–272
   PubMed Web of Science ®Google Scholar
• Ghirardello A, Doria A, Vesco P, Vaccaro E, Bernardi C, Fagiolo U, et al. Blotting pattern of IgG anti-(U1)RNP antibodies in mixed connective tissue disease. Rheumatol Int 1996; 16: 145–150
   PubMedGoogle Scholar
• Ghirardello A, Doria A, Zampieri S, Gerli R, Rapizzi E, Gambari PF. Anti-ribosomal P protein antibodies detected by immunoblotting in patients with connective tissue diseases: Their specificity for SLE and association with IgG anticardiolipin antibodies. Ann Rheum Dis 2000; 59: 875–881
   PubMedGoogle Scholar
• Hoet RM, Koornneef I, de Rooij DJ, van de Putte LB, van Venrooij WJ. Changes in anti-U1 RNA antibody levels correlate with disease activity in patients with systemic lupus erythematosus overlap syndrome. Arthritis Rheum 1992; 35: 1202–1210
   PubMedGoogle Scholar
• Brouwer R, Vree Egberts W, Jongen PH, van Engelen BG, van Venrooij WJ. Frequent occurrence of anti-tRNA (His) autoantibodies that recognize a conformational epitope in sera of patients with myositis. Arthritis Rheum 1998; 41: 1428–1437
   PubMedGoogle Scholar
• Brouwer R, Hengstmam GJ, Vree Egberts W, Ehrfeld H, Bozic B, Ghirardello A, et al. Autoantibodies profiles in the sera of European patients with myositis. Ann Rheum Dis 2001; 60: 116–123
   PubMed Web of Science ®Google Scholar
• Targoff IN, Miller FW, Medsger TA, Oddis CV. Classification criteria for the idiopathic inflammatory myopathies. Curr Opin Rheumatol 1997; 9: 527–535
   PubMedGoogle Scholar
• Zampieri S, Ghirardello A, Rossini K, Iaccarino L, Gambari PF, Doria A. Autoantibodies in idiopathic inflammatory myopathies. Basic Appl Myol 2002; 12: 27–31
   Google Scholar
• Hengstman GJ, Brouwer R, Egberts WT, Seelig HP, Jongen PJ, van Venrooij WJ, et al. Clinical and serological characteristics of 125 Dutch myositis patients. Myositis specific autoantibodies aid in the differential diagnosis of the idiopathic inflammatory myopathies. J Neurol 2002; 249: 69–75
   PubMedGoogle Scholar
• Troyanov Y, Targoff IN, Tremblay JL, Gauler JR, Raymand Y, Senecal JL. Novel classification of idiopathic inflammatory myopathies based on overlap features and autoantibodies. Medicine 2005; 84: 231–249
   PubMed Web of Science ®Google Scholar
• Dalakas MC. Polymyositis, dermatomyositis and inclusion body myositis. Harrison's principles of internal medicine15th ed., E Braunwald, AS Fauci, DL Kasper, SL Hauser, DL Longo, JL Jameson. McGraw-Hill, New York 2001; 2524–2529
   Google Scholar
• Targoff IN. Laboratory testing in the diagnosis and management of idiopathic inflammatory myopathies. Rheum Dis Clin North Am 2002, 28: 859–890
   PubMedGoogle Scholar
• Hill CL, Zhang Y, Sigurgeirsson B, Pukkuda E, Mellemkjaer L, Airio A, et al. Frequency of specific cancer types in dermatomyositis and polymyositis: A population-based study. Lancet 2001; 357: 96–100
   PubMed Web of Science ®Google Scholar
• Rutjes SA, Vree Egberts WTM, Jongen P, van den Hoogen F, Prujin GJM, van Venrooij WJ. Anti-Ro52 antibodies frequently co-occur with anti-Jo-1 antibodies in sera from patients with idiopathic inflammatory myopathy. Clin Exp Immunol 1997; 109: 32–40
   PubMed Web of Science ®Google Scholar
• Takada K, Nagasaka K, Miyasaka N. Polymyositis/dermatomyositis and interstitial lung disease: A new therapeutic approach with T-cell-specific immunosuppressants. Autoimmunity 2005; 38: 383–392
   PubMed Web of Science ®Google Scholar
• Friedman AW, Targoff IN, Arnett FC. Interstitial lung disease with autoantibodies against aminoacyl-tRNA synthetases in the absence of clinically apparent myositis. Semin Arthritis Rheum 1996; 26: 459–467
   PubMed Web of Science ®Google Scholar
• Yoshifuji H, Fujii T, Kobayashi S, Imura Y, Fujita Y, Kawabata D, et al. Anti-aminoacyl-tRNA synthetase antibodies in clinical course prediction of interstitial lung disease complicated with idiopathic inflammatory myopathies. Autoimmunity, in press
   Google Scholar